PTGS2 and congenital bilateral aplasia of vas deferens from CFTR mutation: However, we must consider that CAVD samples were all from patients with a severe stenosis; hence, we cannot rule out COX-2 reduction may occur later during the progression from an asymptomatic initial phase of the disease to severe stenosis that must be treated with valve replacement.